Toru Kubo

5.9k total citations
152 papers, 3.4k citations indexed

About

Toru Kubo is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Molecular Biology. According to data from OpenAlex, Toru Kubo has authored 152 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Cardiology and Cardiovascular Medicine, 32 papers in Epidemiology and 26 papers in Molecular Biology. Recurrent topics in Toru Kubo's work include Cardiomyopathy and Myosin Studies (66 papers), Cardiovascular Function and Risk Factors (35 papers) and Cardiovascular Effects of Exercise (29 papers). Toru Kubo is often cited by papers focused on Cardiomyopathy and Myosin Studies (66 papers), Cardiovascular Function and Risk Factors (35 papers) and Cardiovascular Effects of Exercise (29 papers). Toru Kubo collaborates with scholars based in Japan, United States and United Kingdom. Toru Kubo's co-authors include Hiroaki Kitaoka, Naohito Yamasaki, Yoshinori Doi, Yoshihisa Matsumura, Makoto Okawa, Takayoshi Hirota, Jens Mogensen, William J. McKenna, Takashi Furuno and Yuichi Baba and has published in prestigious journals such as The Lancet, Circulation and Journal of Clinical Investigation.

In The Last Decade

Toru Kubo

142 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toru Kubo Japan 32 2.1k 776 379 344 246 152 3.4k
Najma Latif United Kingdom 28 1.1k 0.5× 761 1.0× 269 0.7× 630 1.8× 411 1.7× 73 2.5k
John P. Veinot Canada 36 2.4k 1.1× 1.0k 1.3× 552 1.5× 1.2k 3.6× 337 1.4× 179 4.5k
Carmela D. Tan United States 26 1.6k 0.8× 596 0.8× 642 1.7× 1.0k 2.9× 147 0.6× 122 3.1k
Yahye Merhi Canada 35 878 0.4× 867 1.1× 223 0.6× 800 2.3× 530 2.2× 120 4.0k
Makoto Handa Japan 42 750 0.4× 954 1.2× 247 0.7× 786 2.3× 165 0.7× 184 5.2k
Reza Ardehali United States 34 1.2k 0.6× 1.9k 2.4× 240 0.6× 1.2k 3.4× 461 1.9× 78 3.9k
Wei Yin United States 28 530 0.3× 288 0.4× 168 0.4× 537 1.6× 446 1.8× 116 2.4k
Takuya Ueno Japan 27 449 0.2× 573 0.7× 518 1.4× 486 1.4× 144 0.6× 92 2.9k
Shigeki Morita Japan 30 692 0.3× 533 0.7× 301 0.8× 1.1k 3.2× 617 2.5× 179 2.8k
J J Sixma Netherlands 39 957 0.5× 704 0.9× 239 0.6× 959 2.8× 249 1.0× 103 5.7k

Countries citing papers authored by Toru Kubo

Since Specialization
Citations

This map shows the geographic impact of Toru Kubo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toru Kubo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toru Kubo more than expected).

Fields of papers citing papers by Toru Kubo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toru Kubo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toru Kubo. The network helps show where Toru Kubo may publish in the future.

Co-authorship network of co-authors of Toru Kubo

This figure shows the co-authorship network connecting the top 25 collaborators of Toru Kubo. A scholar is included among the top collaborators of Toru Kubo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toru Kubo. Toru Kubo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuji, Ichiei, Kenji Fukushima, Hirotaka Maruno, et al.. (2025). Nuclear Medicine Imaging for the Diagnosis of ATTR Cardiac Amyloidosis. PubMed. 11(1). 3–12. 1 indexed citations
2.
Kitada, Shuichi, Junki Yamamoto, Shohei Kikuchi, et al.. (2025). Echocardiographic Features of Wild-Type Transthyretin Cardiac Amyloidosis From J-Case. JACC Asia. 5(5). 633–646.
3.
Kubo, Toru, Shunsuke Inoue, Seitaro Nomura, et al.. (2025). Unveiling Clinical and Genetic Distinctions in Pure‐Apical Versus Distal‐Dominant Apical Hypertrophic Cardiomyopathy. Journal of the American Heart Association. 14(6). e038208–e038208. 1 indexed citations
4.
Kubo, Toru, Yoshinori Murakami, Hironori Yamamoto, et al.. (2024). Prospective Multicenter Screening With High-Sensitivity Cardiac Troponin T for Wild-Type Transthyretin Cardiac Amyloidosis in Outpatient and Community-Based Settings. Circulation Journal. 89(1). 24–30. 3 indexed citations
5.
Izumiya, Yasuhiro, Toru Kubo, Jin Endo, et al.. (2024). Transthyretin Amyloid Cardiomyopathy: Literature Review and Red-Flag Symptom Clusters for Each Cardiology Specialty. ESC Heart Failure. 12(2). 955–967. 2 indexed citations
6.
Baba, Yuichi, Toru Kubo, Takayoshi Hirota, et al.. (2023). High-sensitivity Cardiac Troponin T Is a Useful Biomarker for Predicting the Prognosis of Patients with Systemic Sarcoidosis Regardless of Cardiac Involvement. Internal Medicine. 62(21). 3097–3105. 2 indexed citations
7.
Kubo, Toru & Hiroaki Kitaoka. (2023). Genetic Testing for Cardiomyopathy in Japan 2022: Current Status and Issues of Precision Medicine. Journal of Cardiac Failure. 29(5). 805–814. 4 indexed citations
8.
9.
Kubo, Toru, et al.. (2020). Cardiac manifestations and effects of enzyme replacement therapy for over 10 years in adults with the attenuated form of mucopolysaccharidosis type I. Molecular Genetics and Metabolism Reports. 25. 100662–100662. 6 indexed citations
10.
Yamasaki, Naohito, et al.. (2020). A single atrial septal defect masquerading as multiple defects due to a refraction artifact – A cautionary note. Journal of Cardiology Cases. 22(2). 55–58. 1 indexed citations
11.
Kubo, Toru, et al.. (2017). Abstract 12143: A Validation Study of Phenotype-guided Genetic Testing Using the Mayo HCM Genotype Predictor Score for Japanese Patients With Hypertrophic Cardiomyopathy. Circulation. 1 indexed citations
12.
Kubo, Toru, et al.. (2016). An Abnormal Serum Concentration of High-sensitivity Cardiac Troponin T is Associated with Progression of Left Ventricular Remodeling in Hypertrophic Cardiomyopathy. Circulation. 80. 168. 5 indexed citations
13.
Kubo, Toru, Hiroaki Kitaoka, Shigeo Yamanaka, et al.. (2013). Significance of High-Sensitivity Cardiac Troponin T in Hypertrophic Cardiomyopathy. Journal of the American College of Cardiology. 62(14). 1252–1259. 114 indexed citations
14.
Kitaoka, Hiroaki, Toru Kubo, Yuichi Baba, et al.. (2012). Serum tenascin-C levels as a prognostic biomarker of heart failure events in patients with hypertrophic cardiomyopathy. Journal of Cardiology. 59(2). 209–214. 28 indexed citations
15.
Kitaoka, Hiroaki, Toru Kubo, Makoto Okawa, et al.. (2011). Plasma metalloproteinase levels and left ventricular remodeling in hypertrophic cardiomyopathy in patients with an identical mutation. Journal of Cardiology. 58(3). 261–265. 7 indexed citations
16.
Arimura, Takuro, J. Martijn Bos, Akinori Sato, et al.. (2009). Cardiac Ankyrin Repeat Protein Gene (ANKRD1) Mutations in Hypertrophic Cardiomyopathy. Journal of the American College of Cardiology. 54(4). 334–342. 114 indexed citations
17.
Kubo, Toru, Juan R. Gimeno, Ajay Bahl, et al.. (2007). Prevalence, Clinical Significance, and Genetic Basis of Hypertrophic Cardiomyopathy With Restrictive Phenotype. Journal of the American College of Cardiology. 49(25). 2419–2426. 160 indexed citations
18.
Kubo, Toru, Hiroaki Kitaoka, Makoto Okawa, et al.. (2005). Lifelong Left Ventricular Remodeling of Hypertrophic Cardiomyopathy Caused by a Founder Frameshift Deletion Mutation in the Cardiac Myosin-Binding Protein C Gene Among Japanese. Journal of the American College of Cardiology. 46(9). 1737–1743. 85 indexed citations
19.
Mogensen, Jens, Ross T. Murphy, Toru Kubo, et al.. (2004). Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy. Journal of the American College of Cardiology. 44(12). 2315–2325. 116 indexed citations
20.
Mogensen, Jens, Toru Kubo, Mauricio Duque, et al.. (2003). Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations. Journal of Clinical Investigation. 111(6). 925–925. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Najma Latif Breakdown of academic impact, for papers by John P. Veinot Breakdown of academic impact, for papers by Carmela D. Tan Breakdown of academic impact, for papers by Yahye Merhi Breakdown of academic impact, for papers by Makoto Handa Breakdown of academic impact, for papers by Reza Ardehali Breakdown of academic impact, for papers by Wei Yin Breakdown of academic impact, for papers by Takuya Ueno Breakdown of academic impact, for papers by Shigeki Morita Breakdown of academic impact, for papers by J J Sixma
Rankless by CCL
2026